Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Joshua Boger Insider Profile
4 Followers
Joshua Boger, Director at Vertex Pharmaceuticals, holds 1.06M shares in CervoMed (Ticker: CRVO), holds 361.90K shares in Vertex Pharmaceuticals (Ticker: VRTX).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+5.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joshua Boger holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 06, 2015 - Feb 06, 2016
Return:+20.20%
The most profitable trade made by Joshua Boger
Joshua Boger's Trading History
Vertex Pharmaceuticals
Jun 09, 2017
Director
Uninformative Buy
370.30K
$143.77M
CervoMed
Feb 28, 2024
Director, Ten Percent Owner
Uninformative Buy
―
$2.36M
List of latest transactions for each holding click on a transaction to see Joshua Boger's performance on stock
You May Also Like
Joshua Boger insider profile FAQ
What is the percentage of profitable transactions made by Joshua Boger?
The percentage of profitable transactions made by Joshua Boger is 50%.
What is the average return per transaction made by Joshua Boger?
The average return per transaction made by Joshua Boger is 5.40%.
What stocks does Joshua Boger hold?
Joshua Boger holds: VRTX, CRVO stocks.
What was Joshua Boger’s latest transaction?
Joshua Boger latest transaction was an Uninformative Buy of ―.
What was Joshua Boger's most profitable transaction?
Joshua Boger’s most profitable transaction was an Informative Sell of VRTX stock on February 6, 2015. The return on the trade was 20.20%.
What is Joshua Boger's role in Vertex Pharmaceuticals?
Joshua Boger's role in Vertex Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.